• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up1.57% Nasdaq Up2.12%

    Teva Pharmaceutical Industries Limited (TEVA)

    -NYSE
    49.57 Up 1.04(2.14%) Jun 28, 4:01PM EDT
    |After Hours : 49.57 0.00 (0.00%) Jun 28, 5:30PM EDT
    ProfileGet Profile for:
    Teva Pharmaceutical Industries Limited
    5 Basel Street
    PO Box 3190
    Petach Tikva, 49131
    Israel - Map
    Phone: 972 3 926 7267
    Fax: 972 3 923 4050
    Website: http://www.tevapharm.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Drug Manufacturers - Other
    Full Time Employees:42,888

    Business Summary 

    Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic medicines and a portfolio of specialty medicines worldwide. The company operates in two segments, Generic Medicines and Specialty Medicines. The Generic Medicines segment offers generic medicines, such as sterile products, hormones, narcotics, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments, and creams. This segment also develops, manufactures, and sells active pharmaceutical ingredients. The Specialty Medicines segment provides branded specialty medicines for use in central nervous system and respiratory indications, as well as the women’s health, oncology, and other specialty businesses. Its products in the central nervous system area comprise Copaxone for multiple sclerosis; Azilect for the treatment of Parkinson’s disease; Nuvigil for the treatment of excessive sleepiness associated with narcolepsy and certain other disorders; Fentora®/Effentora for the treatment of breakthrough pain in opioid-tolerant adult patients with cancer; and Zecuity, a prescription transdermal system for the acute treatment of migraine with or without aura in adults. This segment’s products in the respiratory market include ProAir, ProAir Respiclick, QVAR, and Duoresp Spiromax for the treatment of asthma and chronic obstructive pulmonary disease, as well as Treanda, Granix, Trisenox, Synribo, Lonquex, Myocet, Eporatio, Tevagrastim/Ratiograstim, and Trisenox products in the oncology market. This segment also offers a portfolio of products in the women’s health category, which includes ParaGard, Plan B One-Step, OTC/Rx, Zoely, Seasonique, and Ovaleap, as well as other products. Teva Pharmaceutical Industries Limited has alliances and other arrangements with Takeda Pharmaceutical Company Limited and Procter & Gamble Company. The company was founded in 1901 and is headquartered in Petach Tikva, Israel.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Teva Pharmaceutical Industries Limited

    Key Executives 
     PayExercised
    Mr. Erez Vigodman , 57
    Chief Exec. Officer, Pres, Director and Member of Fin. & Invesment Committee
    4.34M0.00
    Mr. Eyal Desheh , 64
    Chief Financial Officer and Group Exec. VP
    2.63M0.00
    Dr. Carlo De Notaristefani Ph.D., 58
    Chief Exec. Officer of Global Operations and Pres of Global Operations
    2.27M0.00
    Dr. Michael R. Hayden CM, OBC, M.B. ChB., Ph.D., FRCP(C), FRSC, 64
    Chief Scientific Officer and Pres of Global R&D
    4.11M0.00
    Mr. Sigurdur Oli Olafsson , 47
    Chief Exec. Officer of Global Generic Medicines Group and Pres of Global Generic Medicines Group
    2.99M0.00
    Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.